Indraprastha Medical Inkomsten in het verleden
Verleden criteriumcontroles 6/6
Indraprastha Medical is de winst gegroeid met een gemiddeld jaarlijks percentage van 38.7%, terwijl de Healthcare industrie de winst jaarlijks groeide met 28.3%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 13.7% per jaar. Het rendement op eigen vermogen van Indraprastha Medical is 28.2%, en het heeft een nettomarge van 11.2%.
Belangrijke informatie
38.7%
Groei van de winst
38.7%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 29.4% |
| Inkomstengroei | 13.7% |
| Rendement op eigen vermogen | 28.2% |
| Nettomarge | 11.2% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Oct 14
We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned
Sep 18Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 30Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 11Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward
Aug 08Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital
Jun 12Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21Opbrengsten en kosten
Hoe Indraprastha Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 13,189 | 1,478 | 1,066 | 0 |
| 30 Jun 24 | 12,861 | 1,382 | 0 | 0 |
| 31 Mar 24 | 12,447 | 1,240 | 1,066 | 0 |
| 31 Dec 23 | 12,040 | 1,126 | 912 | 0 |
| 30 Sep 23 | 11,745 | 1,041 | 912 | 0 |
| 30 Jun 23 | 11,419 | 964 | 0 | 0 |
| 31 Mar 23 | 10,987 | 862 | 895 | 0 |
| 31 Dec 22 | 10,411 | 815 | 552 | 0 |
| 30 Sep 22 | 10,000 | 765 | 552 | 0 |
| 30 Jun 22 | 9,486 | 635 | 0 | 0 |
| 31 Mar 22 | 8,882 | 586 | 552 | 0 |
| 31 Dec 21 | 8,705 | 585 | 284 | 0 |
| 30 Sep 21 | 8,139 | 546 | 284 | 0 |
| 30 Jun 21 | 7,221 | 430 | 0 | 0 |
| 31 Mar 21 | 6,134 | 23 | 285 | 0 |
| 31 Dec 20 | 6,158 | -63 | 510 | 0 |
| 30 Sep 20 | 6,462 | -76 | 510 | 0 |
| 30 Jun 20 | 7,213 | 99 | 510 | 0 |
| 31 Mar 20 | 8,308 | 436 | 510 | 0 |
| 31 Dec 19 | 8,307 | 443 | 483 | 0 |
| 30 Sep 19 | 8,185 | 407 | 483 | 0 |
| 30 Jun 19 | 8,025 | 305 | 0 | 0 |
| 31 Mar 19 | 7,882 | 284 | 483 | 0 |
| 31 Dec 18 | 7,734 | 269 | 437 | 0 |
| 30 Sep 18 | 7,610 | 253 | 437 | 0 |
| 30 Jun 18 | 7,527 | 228 | 0 | 0 |
| 31 Mar 18 | 7,527 | 211 | 437 | 0 |
| 31 Dec 17 | 7,471 | 202 | 448 | 0 |
| 30 Sep 17 | 7,537 | 207 | 448 | 0 |
| 30 Jun 17 | 7,564 | 228 | 0 | 0 |
| 31 Mar 17 | 7,657 | 262 | 437 | 0 |
| 31 Dec 16 | 7,660 | 304 | 437 | 0 |
| 30 Sep 16 | 7,635 | 283 | 437 | 0 |
| 30 Jun 16 | 7,640 | 296 | 437 | 0 |
| 31 Mar 16 | 7,554 | 244 | 428 | 0 |
| 31 Dec 15 | 7,472 | 303 | 937 | 0 |
| 30 Sep 15 | 7,340 | 323 | 937 | 0 |
| 30 Jun 15 | 7,226 | 321 | 0 | 0 |
| 31 Mar 15 | 7,145 | 325 | 412 | 0 |
| 31 Dec 14 | 7,016 | 321 | 784 | 0 |
| 30 Sep 14 | 6,949 | 331 | 784 | 0 |
| 30 Jun 14 | 6,897 | 342 | 0 | 0 |
| 31 Mar 14 | 6,776 | 354 | 805 | 0 |
| 31 Dec 13 | 6,663 | 347 | 660 | 0 |
Kwaliteitswinsten: INDRAMEDCO heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (11.2%) INDRAMEDCO } zijn hoger dan vorig jaar (8.9%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van INDRAMEDCO is de afgelopen 5 jaar aanzienlijk gegroeid met 38.7% per jaar.
Versnelling van de groei: De winstgroei van INDRAMEDCO over het afgelopen jaar ( 42% ) overtreft het 5-jarig gemiddelde ( 38.7% per jaar).
Winst versus industrie: De winstgroei INDRAMEDCO over het afgelopen jaar ( 42% ) overtrof de Healthcare -sector 30.6%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 28.2% ) van INDRAMEDCO wordt als hoog beschouwd.